Look At Analyst Expectations For A Better Read On Crinetics Pharmaceuticals Inc (NASDAQ: CRNX)
Currently, there are 66.80M common shares owned by the public and among those 56.99M shares have been available to trade. Insiders at the company have transacted a total of 40 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 22 of these insider trades were purchases, […]
